However, genetic mutations in NFE2L2-KEAP1 genes responsible for activating the antioxidant and anti-inflammatory response could affect the signaling pathway, causing phenotypes with greater susceptibility to infection and even more severe COVID-19 [20]. This evidence concerns the gene KEAP1 and COVID-19.